“In vitro” proceed to test for coronavirus in Moscow

Moscow laboratory “Invitro” start testing for coronavirus infection COVID-19. As in Novosibirsk, it acts as a centralized laboratory. The laboratory accepts biomaterials obtained from patients in Moscow clinics and hospitals, and will perform up to 1000 tests per day.

Laboratory and diagnostic uses complex test system of the Russian producer JSC “Vector-best”. The test system has high sensitivity of detection of RNA of the coronavirus SARS-CoV-2 – 1×10*3 copies/ml of the original sample and specificity of 100%. To assess analytical specificity of the manufacturer’s tests were conducted with potentially interfering viruses (influenza A and b, parainfluenza, adenovirus infection, respiratory syncytial infection, metapneumovirus infection, rhinovirus infection and coronavirus infection of man, caused by hCov NL63, hCov OC43, hCov 229E, hCov HKUI) and microorganisms (Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Staphylococcus aureus). Cross-reacting viruses and microorganisms were found.

Part of the premises clinical diagnostic laboratory translated into a special mode of operation thus to provide an efficient and secure for the employees the process of working with samples. Was allocated premises and equipment, prepared the required number of personal protective equipment, employees have received special training and will only perform this type of studies, 7 days a week.

As previously reported, testing for the coronavirus group “Invitro” is part of the system of measures of state and national health system in the fight against the pandemic. Significant technological, organizational and human resources group is aimed at conducting research on the coronavirus as a centralized laboratory. At the same time a rejection of the capture of biomaterials in medical offices, the company will eliminate an additional risk factor and provides a safe environment for all patients during visits to medoviy “Invitro”. The need for urgent and immediate laboratory diagnosis remains unchanged even in the current difficult epidemiological conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]